Artal Group S.A. Ikena Oncology, Inc. Transaction History

Artal Group S.A.

  • $214 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$1.33 - $4.4 $1.13 Million - $3.74 Million
-850,000 Reduced 45.96%
999,513 $1.97 Million
Q2 2023

Aug 11, 2023
BUY
$3.5 - $7.31 $1.05 Million - $2.19 Million
300,000 Added 19.36%
1,849,513 $12.1 Million
Q1 2021

May 14, 2021
BUY
$25.6 - $32.0 $39.7 Million - $49.6 Million
1,549,513 New
1,549,513 $43.8 Million

Others Institutions Holding IKNA

# of Institutions
62
Shares Held
30.6M
Call Options Held
0
Put Options Held
0
View Full List

About Ikena Oncology, Inc.

IKNA Quotes by TradingView
  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $61.3M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email